FDA Penalizes Mammography Center

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 7 No 10
Volume 7
Issue 10

ROCKVILLE, Md--A Chicago mammography facility, known as CMI, has agreed to pay a $30,000 fine and to cease operating in the mammography field for 5 years. The FDA had accused it of performing mammography exams without

ROCKVILLE, Md--A Chicago mammography facility, known as CMI, has agreed to pay a $30,000 fine and to cease operating in the mammography field for 5 years. The FDA had accused it of performing mammography exams without accreditation, a violation of the Mammography Quality Standards Act of 1992. Both CMI and its president, Thomas E. Miller, will remove themselves from the mammography field and jointly pay $25,000. The facility’s supervisory radiologist will pay $5,000. The case is the first time a mammography facility has been required to pay a civil money penalty under the Act.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
CAR T-cell therapy initially developed for mantle cell lymphoma was subsequently assessed in marginal zone lymphoma.
The efficacy of the BOVen regimen in chronic lymphocytic leukemia facilitated its evaluation in patients with mantle cell lymphoma.
2 experts in this video
2 experts in this video
Beta emitters like 177Lu-rosopatamab may offer built-in PSMA imaging during the treatment of patients with metastatic castration-resistant prostate cancer.
Ongoing ctDNA analysis may elucidate outcomes associated with divarasib plus migoprotafib for those with KRAS G12C–positive NSCLC.